Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273884
Status:
COMPLETED
Last Update Posted:
2007-02-19
First Post:
2006-01-05
Brief Title:
Amonafide in Combination With Cytarabine in Secondary AML
Sponsor:
Xanthus Pharmaceuticals Inc
Organization:
Xanthus Pharmaceuticals Inc
Organization Data
Organization:
Xanthus Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
0001A3-200-GL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xanthus Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None